Helicobacter pylori inhibits expression of heat shock protein 70 (HSP70) in human epithelial cell line. Importance of Cag A protein

Journal of Physiology and Pharmacology

Volumn 57, Issue 2, 2006, Pages 265-278

  Targosz, A ^a   Pierzchalski, P ^a   Krawiec, A ^a   Szczyrk, U ^a   Brzozowski, T ^a   Konturek, S J ^a   Pawlik, W W ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Bacterial infection; CagA; Heat shock protein 70; Helicobacter pylori; Human epithelial cells; PAI

Indexed keywords

CAGA PROTEIN; HEAT SHOCK PROTEIN 70; RECOMBINANT PROTEIN; RNA; VACUOLATING TOXIN;

ARTICLE; CELL ISOLATION; EPITHELIUM CELL; GENE EXPRESSION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; INCUBATION TIME; INHIBITION KINETICS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL LINE, TUMOR; EPITHELIAL CELLS; GENE EXPRESSION; HELICOBACTER PYLORI; HSP70 HEAT-SHOCK PROTEINS; HUMANS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TIME FACTORS;

EID: 33746034219     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Becker J, Craig JE. Heat shock proteins as molecular chaperones. Eur J Biochem 1994; 219: 11-23.
2. Konturek JW, Fischer H, Konturek PC, et al. Heat shock protein to (HSP70) in gastric adaptation to aspirin in Helicobacter pylori infection. J Physiol Pharmacol 2001; 52,1:153-164.
3. Lu XP, Omar RA, Hang WWL. Immunocytochemical expression of the 70 kD heat-shock protein in ischaemic bowel disease. J Pathol 1996; 179: 409-413.
4. Robert J, Monoret A, Basu S, et al. Phylogenetic conservation of the molecular and immunological properties of the chaperons HSP96 and HSP70. Eur J Immunol 2001; 31: 186-195.
5. Rokutan K. Role of heat shock protein in gastric mucosal protection. J Gastroenterol Hepatol 2000; 15: D12-D17.
6. Multhoff G, Botzler C, Jennen L, et al. Heat-shock protein 72 on tumor cells. J Immunol 1997; 158: 4341-4350.
7. Bukau B, Horwich AL. The hsp60 and hsp70 chaperon machines. Cell 1998; 92: 351-356.
8. Canoz O, Belenli O, Patriroglu TE. General features of gastric carcinomas and comparison of HSP70 and NK cell immunoreactivity with prognostic factors. Pathol Oncol Res 2000; 8: 262-269.
9. Backert S, Ziska E, Brinkmann V, et al. Translocation of the Helicobacter pylori cagA protein in gastric epithelial cells by a type IV secretion apparatus. Cellular Microbiol 2000; 2,2:155-164.
10. Windsor HM, O'Rourke KL. Bacteriology and taxonomy of Helicobacter pylori. Gastroenterol Clin of North Amer 2000; 29: 633-648.
11. Marshall BJ, Barrett L, Prakash C, McCallum RW, Guerrant RL. Urea protects Helicobacter pylori from the bactericidal effect of acid. Gastroenterology 1990; 53:353-387.
12. Mobley HLT. The role of Helicobacter pylori urease in pathogenesis of gastritis and peptic ulceration. Aliment Pharmacol Ther 1996: 10,1: 57-64.
13. Westblom TU. Molecular diagnosis of Helicobacter pylori. Immunol Invest 1997; 26: 163-174.
14. Dunn BE, Vakil NB, Schneider BG, et al. Localization of Helicobacter pylori urease and heat shock protein in human gastric biopsies. Infect Immun 1997: 65: 1181-1188.
15. Konturek SJ, Konturek PC, Pawlik T, Sliwowski Z, Ochmanski W, Hahn EG. Duodenal mucosal protection by bicarbonate secretion and its mechanisms. J Physiol Pharmacol 2004; 55 Suppl 2: 5-17.
16. Hata Y, Mrakami M, Okabe S. Glycoconjugates with NeuAc-NeuAc-Gal-Glc are more effective at preventing adhesion of Helicobacter pylori to gastric epithelial cells than glycoconjugates with NeuAc-Gal-Glc. J Physiol Pharmacol 2004; 55: 607-625.
17. Forman D. Helicobacter pylori: The gastric cancer problem. Gut 1998; 43,1:S33-34.
18. Wee A, Kang JY, Teh M. Helicobacter pylori and gastric cancer: correlation with gastritis, intestinal metaplasia and tumor histology. Gut 1992; 33: 1029-1032.
19. Covacci A, Telford JL, del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999; 21: 1328-1333.
20. Cover TL, Blaser MJ. Helicobacter pylori factors associated with disease. Gastroenterology 1999; 117: 257-261.
21. Moss SF. The carcinogenic effect of H. Pylori on the gastric epithelial cell. J Physiol Pharmacol 1999; 50: 847-856.
22. Akopyants NS, Clifton SW, Kersulyte D, et al. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998; 28: 37-53.
23. Censini S, Lange C, Xiang Z, et al. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-16653.
24. Ge Z, Taylor DE. Contributions of genome sequencing to understanding the biology of Helicobacter pylori. Annual Rev Microbiol 1999; 53: 353-387.
25. Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogenicity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997; 112: 92-99.
26. Go MF, Crowe SE. Virulence and pathogenicity of Helicobacter pylori. Gastroenterol Clin of North Amer 2000; 29: 649-670.
27. Arabski M, Blasiak J. Molecular aspects of Helicobacter pylori infection. Postȩpy biologii komórki 2003; 30: 679-694.
28. Cover TL, Krishna US, Dawn AI, Peek RM. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res 2003; 63: 651-657.
29. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of cagA phossphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 2004; 127: 514-523.
30. Guillemin K, Salama NR, Tompkins LS, Falkow S. Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc Natl Acad Sci 2002; 99:15136-15141.
31. Covacci A, Rappuoli R. Tyrosine-phosorylated bacterial proteins: Trojan horses for host cell. J Exp Med 2000; 191:587-592.
32. Al-Ghoul L, Wessler S, Hundertmark T, et al. Analysis of the type IV secretion system-dependent cell motility of Helicobacter pylori-infected epithelial cells. Biochem and Biophys Res Comm 2004; 322:860-866.
33. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of Helicobacter pylori cagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 2000; 97: 1263-1268.
34. Shibata W, Hirata Y, Yoshida H, et al. NF-kappaB and ERK-signaling pathways contribute to the gene expression induced by cagPAI-positive- Helicobacter pylori infection. World J Gastroenterol 2005;11:6134-6143.
35. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidiumthiocyanatephenol-chloroform extraction. Anal Biochem 1987; 162: 16-159.
36. Brzozowski T. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment - Polish achievements. J Physiol Pharmacol 2003; 54: 99-126.
37. Kanatani K, Ebata M, Murakami M, Okabe S. Effects of indomethacin and rofecoxib on gastric mucosal damage in normal and Helicobacter pylori-infected Mongolian gerbils. J Physiol Pharmacol 2004; 55 (1 Pt 2): 207-222.
38. Nylandsted J, Brand K, Jaattela M. Heat shock protein 70 is required for survival of cancer cells. Ann N Y Acad Sci 2000; 926:122-125.
39. Wong HR, Finder JD, Hausner GJ, Wasserloos K, Pitt BR. Expression of iNOS in cultured rat pulmonary artery smooth muscle cells in inhibited by the heat shock response. Am J Physiol 1995; 6: L843-848.
40. Konturek PC, Kania J, Kukharsky V, Ocker S, Hahn EG, Konturek SJ. Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor ad apoptosis-related proteins in gastric epithelial cells. J Physiol Pharmacol 2003; 54:17-32.
41. Reider G, Merchant JL, Haas R. Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology 2005; 128: 1229-1242.
42. Asahi M, Azuma T, Ito S, et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000: 191; 593-602.
43. Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 2001; 42: 1337-1348.
44. Pierzchalski P, Krawiec A, Ptak-Belowska A, Baranska A, Konturek SJ, Pawlik WW. The mechanism of heat-shock protein 70 gene expression abolition in gastric epithelium caused by Helicobacter pylori infection. Helicobacter 2006, 11, (in press).
45. Amieva MR, Vogelmann R, Covacci A, et al. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003; 300:1430-1434.
46. Yeo M, Park HK, Kim DK, et al. Restoration of heat shock protein70 suppresses gastric mucosal inducible nitric oxide synthase expression induced by Helicobacter pylori. Proteomics 2004; 4: 3335-3342.
47. Hirakawa T, Rokutan K, Nikawa T, Kishi K. Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 1996; 111: 345-357.
48. Snyder YM, Guthrie L, Evans GF. Transcriptional inhibition of endotoxin induced monokine synthesis following heat shock in murine peritoneal macrophages. J Leuk Biol 1992; 51:181-187.